What Healthcare Providers Are Doing to Promote Regulatory Compliance

Slides:



Advertisements
Similar presentations
Physicians Regulatory Insurance Program Presenter: Jay Lynch President Presenter: Jay Lynch President.
Advertisements

Managing Resources Responsibly Chapter 3. Factors Affecting Costs of Health Care.
© 2009 Cengage Learning. All Rights Reserved. Healthcare Fraud and Abuse.
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
2010 Region II Conference Corporate Compliance Panel June 3, 2010
Compliance Programs after The Affordable Care Act Angela Mattie, JD, MPH Teresa Tai, PhD, MA Quinnipiac University, School of Business, Department.
The Law of Corporate Governance Rupert Nevin Partner Gordons Cranswick.
Building a Compliance Risk Monitoring Program HCCA Compliance Institute New OrleansApril 19, 2005 Lois Dehls Cornell, Esq. Assistant Vice President, Deputy.
Management, Inc 2012 Hospital Owned Group Management.
© Copyright 2013 Hewlett-Packard Development Company, L.P. The information contained herein is subject to change without notice. Fraud and Abuse in Medicare-What.
The Institutionalization of Business Ethics
CIA’s - The IRO & Shadow Audits Robert F. Bacon, MHA, Director University of Pennsylvania Health System Office of Billing Compliance.
Copyright © 2005 Thomson Delmar Learning. ALL RIGHTS RESERVED.1 This product was funded by a grant awarded under the President’s Community-Based Job Training.
COMPLIANCE PROGRAM. Agenda  Initial Scenarios  Review of General Compliance Information  Review UCP’s Compliance Program  Questions and Discussion.
CORPORATE COMPLIANCE Tim Timmons Vice President Compliance and Regulatory Services Health Future, LLC.
OIG COMPLIANCE GUIDANCE FOR PHYSICIAN PRACTICES Washington County Hospital Association, Inc. CME Program October 26, 2000.
Managing the Privacy Function at a Large Company Kimberly S. Gray, Esq., CIPP Chief Privacy Officer Highmark Inc.
Establishing A Compliance Program: It Makes Sense
Page 1 of 23 DMC’S COMMITMENT TO COMPLIANCE: COMPLIANCE PROGRAM CODE OF CONDUCT 2009 DMC Corporate Audit and Compliance Department Detroit Medical Center©
MA. EXPORT CENTER COMPLIANCE CLINIC
KEY ENFORCEMENT ISSUES - The Government's Perspective Kathleen Meriwether Assistant United States Attorney Eastern District of Pennsylvania UNITED STATES.
Current Issues in Pharmaceutical and Medical Device Compliance Management Introductory Comments Pharma, Medical Device & Biotech Colloquium June 6, 2005.
Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved.McGraw-Hill/Irwin.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
MA. EXPORT CENTER COMPLIANCE EXPORT EXPO Presented by : Paul Divecchio –DiVecchio & Associates Phone: (617) , Fax: (508)
Agenda for Session Compliance in Clinical Research
V May 26 – Thomas DEVRED Baker & McKenzie - Paris The International Medical Devices Compliance Congress and Best Practices.
Welcome….!!! CORPORATE COMPLIANCE PROGRAM Presented by The Office of Corporate Integrity 1.
Patrick Sulzberger, CPA, CHC Compliance & The Board A Guide to Excellence.
Overview of ONC Report to Congress on Health Information Blocking Presented to the Health IT Policy Committee, Task Force on Clinical, Technical, Organizational,
FRAUD, ABUSE & COMPLIANCE.  An intentional deception or misrepresentation made by an individual who knows that the false information reported could result.
0 Due Diligence Monitoring and Auditing of Third Party Vendors October 28, 2008 Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
Legal, Regulations, Investigations, and Compliance Chapter 9 Part 2 Pages 1006 to 1022.
1 Building a Compliance Program in a Small Cap Company The Seventh Annual Pharmaceutical Compliance and Best Practices Forum November 9, 2006 Colleen CravenJanice.
Compliance at the Crossroads: How can the Compliance Profession Move to the Second Generation? A Practical Approach to Integrating Compliance, Risk and.
jasa.org Board of Directors Presentation & Training February 24 th, 2016 Corporate Compliance Program.
Catherine A. Martin Principal Co-Chair - Health Law Department Ober|Kaler Presented by Amy Dilcher Vice President & General Counsel Meritus Health Hagerstown,
F Designed to give you knowledge and application of: Section A: Business organisational structure, governance & management A1. The business organisation.
DMC Research Compliance Our mission is to assure that all research at the DMC is ethical, safe and compliant with regulatory standards; and to support.
crimes-report
Fraud Enforcement Risks and Compliance Solutions Katie Arnholt Deputy Branch Chief Office of Counsel to the Inspector General.
Vendor Management by Banks: How Law Firms Are Affected Peter Swire Huang Professor of Law and Ethics Scheller College of Business Georgia Institute of.
Chapter 4 The Legal and Regulatory Environment of Health Care.
1 - 1 CHAPTER 1 Introduction to Healthcare Finance Definition of healthcare finance Course goal The role of healthcare finance Finance department structure.
COMPLIANCE PROGRAM & CODE OF CONDUCT (YOUR AGENCY)
FRAUD, WASTE & ABUSE WHAT YOU NEED TO KNOW STCHCN – 12/7/2015.
Refuah Community Health Collaborative (RCHC) PPS
Summary Projected Business Landscape Physician Employment's Role
THE INSURANCE INDUSTRY
Corporate Responsibility
First Impressions and an Ethical Foundation
Chapter 3 Legal Issues.
What is HIPAA? HIPAA stands for “Health Insurance Portability & Accountability Act” It was an Act of Congress passed into law in HEALTH INSURANCE.
Thomas B. Valuck, MD, JD Medical Officer & Senior Adviser
Action Items: Monitoring Off-Label Promotion Do’s and Don’t’s
Putting Patients First by Reducing Administrative Tasks in Health Care: A Position Paper of the American College of Physicians March 30, 2017 ACP Medical.
PHARMA AUDIOCONFERENCE An Analysis of the HHS OIG Draft Compliance Program Guidance for the Pharmaceutical Industry Overview of Draft CPG Michael P.
PEM PAL IA COP Internal Control Working Group COSO Principles
Legal, Regulatory & Compliance
Internal control - the IA perspective
What Every Employee Should Know About Compliance.
Current Top 10 List JAMES G. SHEEHAN Associate United States Attorney
COMPLIANCE PROGRAM.
Risk Management: why and how to protect your health center
Compliance, Ethics, and Audit
Numbers-Numbers-Numbers
CMS Gainsharing Demonstration Projects
Value-Based Healthcare: The Evolving Model
An overview of Internal Controls Structure & Mechanism
Public Procurement and PFM
Presentation transcript:

What Healthcare Providers Are Doing to Promote Regulatory Compliance The Medical Device Regulatory, Reimbursement and Compliance Congress March 29, 2007 Jeffrey G. Micklos, Esq. Senior Vice President, Business Operations & General Counsel

Session Overview Current compliance landscape for hospitals Importance of a culture of compliance Involvement of corporate governance Federal enforcement priorities Hospital compliance initiatives that affect medical device companies

Current Compliance Landscape for Hospitals Hospitals have been under scrutiny by federal law enforcement for many years. DOJ/OIG has pursued hospitals through several national initiatives. e.g., lab unbundling, pneumonia upcoding. Despite increased focus on other health care sectors, cases against hospitals continue e.g., Medicare outlier payments; payments for medically unnecessary services; cost reporting issues.

Culture of Compliance Compliance risk management is a must for everyone in health care. A compliance culture is critical; government’s focus is now on effective compliance programs. Regulatory compliance is not the only goal; focus on ethical decision making is now important too. Federal government is looking for more personal accountability when things go wrong.

Corporate Governance and Risk Minimization Recent accounting scandals show a need for a better connection between governance and compliance risk management. SOX protections are seen as important for all corporate entities. Law enforcement is increasingly interested in the knowledge/actions of a corporate board on matters. Directors and/or officers are being targeted; sanctioning the corporate entity is no longer the only remedy.

Federal Enforcement Priorities DOJ/OIG’s enforcement has been widened significantly to other types of providers, suppliers, and individuals. Focus is now on downstream suppliers too. Pharma has been a focus in recent years. Medical device companies are next. New Jersey investigation is a precursor. Scrutiny of hospital supply chain will continue.

Hospital Compliance Initiatives Related to Medical Devices Physician/medical device company arrangements Credentialing of Health Care Industry Representatives (HCIRs) Gainsharing programs

Medical Device Company/Physician Arrangements Hospitals are increasingly interested in arrangements between their medical staff physicians and medical device companies. Illegal arrangements could subject hospitals to fraud liability for billing for services related to those arrangements. Surgeon-owned device companies present a real concern. Fair market value is a difficult issue for hospitals to understand or even to get at.

Credentialing of HCIRs For various reasons, hospitals should maintain oversight of HCIRs inside hospitals. Goal is for an effective credentialing process that does not unduly burden all parties. Policies should differentiate rules based on the roles of specific HCIRs. Ongoing monitoring of compliance – both HCIRs and medical staff physicians – is important to an effective process.

Gainsharing Arrangements Physician satisfaction is critical for hospitals. Aligning incentives should lead to more efficient care and higher quality services. Legal impediments remain, although the OIG has given recently more reason for hope. The DRA demonstration projects will be watched with interest by all parties.

E-mail: jmicklos@fah.org Questions/Comments? Now . . . Later . . . Jeff Micklos Phone: 202.624.1521 E-mail: jmicklos@fah.org